News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CUE market cap is 49.35M. The company's latest EPS is USD -0.5410 and P/E is -1.20.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.82M | 1.72M | 2.66M | 3.34M | 1.58M |
| Operating Income | -13.68M | -12.67M | -10.38M | -8.91M | -9.63M |
| Net Income | -13.53M | -12.35M | -10.17M | -8.66M | -9.59M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.15M | 14.94M | 1.25M | 5.49M | 9.29M |
| Operating Income | -45.04M | -43.71M | -53.5M | -51.99M | -41.59M |
| Net Income | -44.79M | -44.16M | -53.01M | -50.73M | -40.77M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 61.53M | 53.95M | 42.33M | 44.81M | 32.19M |
| Total Liabilities | 24.45M | 23.91M | 20.71M | 19.44M | 14.69M |
| Total Equity | 37.09M | 30.04M | 21.62M | 25.37M | 17.5M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 99.53M | 83.4M | 91.28M | 61.53M | 32.19M |
| Total Liabilities | 20.62M | 17.91M | 25.6M | 24.45M | 14.69M |
| Total Equity | 78.91M | 65.49M | 65.68M | 37.09M | 17.5M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -39.96M | -9.78M | -19.77M | -27.3M | -36.33M |
| Investing | 25M | -55k | -65k | 33k | 32k |
| Financing | 11.86M | 2.35M | 1.35M | 11.18M | 10.24M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -32.49M | -38.84M | -41.81M | -39.96M | -36.33M |
| Investing | 4.46M | 9.11M | -24.61M | 25M | 32k |
| Financing | 58.61M | 19.23M | 53.66M | 11.86M | 10.24M |
| Market Cap | 49.35M |
| Price to Earnings Ratio | -1.20 |
| Price to Sales Ratio | 5.27 |
| Price to Cash Ratio | 2.18 |
| Price to Book Ratio | 2.8 |
| Dividend Yield | - |
| Shares Outstanding | 75.35M |
| Average Volume (1 week) | 449.96k |
| Average Volume (1 Month) | 196.74k |
| 52 Week Change | -53.87% |
| 52 Week High | 1.9891 |
| 52 Week Low | 0.45 |
| Spread (Intraday) | 0.1 (13.7%) |
| Company Name | Cue Biopharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cuebiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
